P. Rebolledo
Scientific Reports · 2021–2023
A researcher in the Science corpus: 3 papers; trusts 0 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Papers from P. Rebolledo's perspective
Ordered by how strongly the researchers P. Rebolledo trusts endorse each paper. Same corpus, a different order for every researcher.
- Comparison of adaptive pacing therapy, cognitive behaviour therapy, graded exercise therapy, and specialist medical care for chronic fatigue syndrome (PACE): a randomised trial
- Clinical sequelae of COVID-19 survivors in Wuhan, China: a single-centre longitudinal study (Clinical Microbiology and Infection)
- Developing and evaluating complex interventions: the new Medical Research Council guidance
- Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. (International Journal of Surgery)
- CONSORT for Reporting Randomized Controlled Trials in Journal and Conference Abstracts: Explanation and Elaboration (PLoS Medicine)
- Assessing Risk of Bias in Included Studies
- CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials (British medical journal)
- Improving the quality of reporting in randomised controlled trials. (Journal of Wound Care)
- Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): The TRIPOD statement
- The CARE Guidelines: Consensus-based Clinical Case Report Guideline Development (Journal of Dietary Supplements)
Their papers
- Development of a Definition of Postacute Sequelae of SARS-CoV-2 Infection. (2023) — 670 citations
- More than 50 long-term effects of COVID-19: a systematic review and meta-analysis (2021) — 1,731 citations
- More Than 50 Long-Term Effects of COVID-19: A Systematic Review and Meta-Analysis (2021) — 703 citations